Adhesion Barrier Market: Examining the Impact of Minimally Invasive Surgery

The global adhesion barrier market was valued at USD 859.95 million in 2022 and is projected to reach USD 1.50 billion by 2030, exhibiting a CAGR of 7.3% from 2023 to 2030. The market's growth is driven by a rising geriatric population and an increasing number of surgical procedures, particularly invasive surgeries with a high risk of postoperative complications.

Despite this growth, the market faces challenges related to accessibility, a lack of health education, and a general lack of awareness about the importance of treatment for post-operation adhesions. However, several factors are expected to drive significant market growth, including improvements in healthcare infrastructure, the increasing availability of trauma care centers, and a growing incidence of sports-related injuries. Recent data from Stanford Children's Health indicates that over 10% of the approximately 30 million children who participate in sports each year experience injuries.

**** 

Key Market Trends & Insights

• North America dominated the market in 2022, holding the largest revenue share. This is attributed to the presence of major players like Johnson & Johnson and Baxter International, as well as a high prevalence of orthopedic conditions and the adoption of advanced treatment procedures in the U.S.
• Based on product, synthetic adhesion barriers accounted for the largest market size due to their high bioresorbability, biocompatibility, and cost-effectiveness. The widespread availability of commercial synthetic barriers also contributes to their dominance.
• By formulation, the film/mesh segment held the largest market share in 2022 and is expected to maintain its dominance. This is due to their low cost and increasing use in various surgical procedures.
• In terms of application, cardiovascular surgeries dominated the market and are projected to grow at the fastest CAGR. This growth is driven by the rising incidence of heart-related diseases and the increasing use of adhesion barriers in these procedures. A 2020 study in the Annals of Medicine and Surgery also noted the benefits of adhesion barriers in preventing peristomal adhesion.

**** 

Order a free sample PDF of the Adhesion Barrier Market Intelligence Study, published by Grand View Research.

**** 

Market Size & Forecast

• 2022 Market Size: USD 859.95 million
• 2030 Projected Market Size: USD 1.50 billion
• CAGR (2023 to 2030): 7.3%
• North America: Largest market in 2022

**** 

Key Companies & Market Share Insights

Companies are employing strategies such as product launches, mergers & acquisitions, and partnerships to maintain their market share. For example, Gunze launched the TENALEAF absorbable adhesion barrier in Japan in 2022, a move aimed at expanding its product portfolio and strengthening its competitive position.

Key Players

• Sanofi S.A.
• Becton Dickinson and Company
• Baxter International, Inc.
• Johnson & Johnson
• Anika Therapeutic, Inc.
• FzioMed, Inc,
• Mast Biosurgery, Inc.,
• Innocoll Holdings PLC
• Atrium Medical Corporation (A part of Getinge Group).

**** 

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

**** 

Conclusion

The adhesion barrier market is poised for significant growth, driven by a global increase in surgical procedures and specific health conditions. While challenges like a lack of awareness persist, the market's trajectory is positive due to key factors like improvements in healthcare infrastructure and strategic moves by major companies. Synthetic barriers and film/mesh formulations are leading the market, with cardiovascular surgeries being a key application area for future growth.